<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnagi.2023.1122927</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Classification and prediction of cognitive trajectories of cognitively unimpaired individuals</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Young Ju</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2177188/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Si Eun</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2136175/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hahn</surname> <given-names>Alice</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jang</surname> <given-names>Hyemin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1671510/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Jun Pyo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/946895/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Hee Jin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/908700/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Na</surname> <given-names>Duk L.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chin</surname> <given-names>Juhee</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Seo</surname> <given-names>Sang Won</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2021;</sup></xref>
</contrib>
<on-behalf-of>Alzheimer&#x2019;s Disease Neuroimaging Initiative</on-behalf-of>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2021;</sup></xref>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Neuroscience Center, Samsung Medical Center</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine</institution>, <addr-line>Busan</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Mental Health, Johns Hopkins Bloomberg School of Public Health</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine</institution>, <addr-line>Indianapolis, IN</addr-line>, <country>United States</country></aff>
<aff id="aff6"><sup>6</sup><institution>Institute of Stem Cell and Regenerative Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff7"><sup>7</sup><institution>Samsung Alzheimer Research Center, Samsung Medical Center</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff8"><sup>8</sup><institution>Center for Clinical Epidemiology, Samsung Medical Center</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff9"><sup>9</sup><institution>Department of Health Sciences and Technology</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff10"><sup>10</sup><institution>Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences &#x0026; Technology (SAIHST), Sungkyunkwan University</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Rong Chen, University of Maryland, Baltimore, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Chenlu Gao, Brigham and Women&#x2019;s Hospital and Harvard Medical School, United States; Ya Fang, Xiamen University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Sang Won Seo, <email>sangwonseo@empas.com</email></corresp>
<corresp id="c002">Juhee Chin, <email>juheechin@hanmail.net</email></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn003"><p><sup>&#x2021;</sup>Data used in the preparation of this article were obtained from the Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) database (<ext-link ext-link-type="uri" xlink:href="https://adni.loni.usc.edu">adni.loni.usc.edu</ext-link>). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analyses or writing of this report. A complete listing of ADNI investigators can be found at: <ext-link ext-link-type="uri" xlink:href="http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf">http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf</ext-link></p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Alzheimer&#x2019;s Disease and Related Dementias, a section of the journal Frontiers in Aging Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>15</volume>
<elocation-id>1122927</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>02</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Kim, Kim, Hahn, Jang, Kim, Kim, Na, Chin and Seo.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Kim, Kim, Hahn, Jang, Kim, Kim, Na, Chin and Seo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>Efforts to prevent Alzheimer&#x2019;s disease (AD) would benefit from identifying cognitively unimpaired (CU) individuals who are liable to progress to cognitive impairment. Therefore, we aimed to develop a model to predict cognitive decline among CU individuals in two independent cohorts.</p>
</sec>
<sec>
<title>Methods</title>
<p>A total of 407 CU individuals from the Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) and 285 CU individuals from the Samsung Medical Center (SMC) were recruited in this study. We assessed cognitive outcomes by using neuropsychological composite scores in the ADNI and SMC cohorts. We performed latent growth mixture modeling and developed the predictive model.</p>
</sec>
<sec>
<title>Results</title>
<p>Growth mixture modeling identified 13.8 and 13.0% of CU individuals in the ADNI and SMC cohorts, respectively, as the &#x201C;declining group.&#x201D; In the ADNI cohort, multivariable logistic regression modeling showed that increased amyloid-&#x03B2; (A&#x03B2;) uptake (&#x03B2; [SE]: 4.852 [0.862], <italic>p</italic> &#x003C; 0.001), low baseline cognitive composite scores (&#x03B2; [SE]: &#x2212;0.274 [0.070], <italic>p</italic> &#x003C; 0.001), and reduced hippocampal volume (&#x03B2; [SE]: &#x2212;0.952 [0.302], <italic>p</italic> = 0.002) were predictive of cognitive decline. In the SMC cohort, increased A&#x03B2; uptake (&#x03B2; [SE]: 2.007 [0.549], <italic>p</italic> &#x003C; 0.001) and low baseline cognitive composite scores (&#x03B2; [SE]: &#x2212;4.464 [0.758], <italic>p</italic> &#x003C; 0.001) predicted cognitive decline. Finally, predictive models of cognitive decline showed good to excellent discrimination and calibration capabilities (C-statistic = 0.85 for the ADNI model and 0.94 for the SMC model).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our study provides novel insights into the cognitive trajectories of CU individuals. Furthermore, the predictive model can facilitate the classification of CU individuals in future primary prevention trials.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cognitive trajectory</kwd>
<kwd>cognitively unimpaired</kwd>
<kwd>nomogram</kwd>
<kwd>prediction</kwd>
<kwd>classification</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="4"/>
<equation-count count="2"/>
<ref-count count="45"/>
<page-count count="10"/>
<word-count count="7799"/>
</counts>
</article-meta>
</front>
<body>
 <sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Populations around the world are aging more rapidly, and aging-related health issues and diseases are projected to lead to greater societal and economic burdens (<xref ref-type="bibr" rid="B37">Patterson, 2018</xref>). As individuals age, they may experience progressive physiological (&#x201C;normal&#x201D;) cognitive decline, although each follows a unique trajectory (<xref ref-type="bibr" rid="B9">Deary et al., 2009</xref>). In particular, reductions in memory, conceptual reasoning, and processing speed are frequently observed in aged individuals (<xref ref-type="bibr" rid="B7">Committee on the Public Health Dimensions of Cognitive Aging et al., 2015</xref>). Pathological cognitive decline may occur due to Alzheimer&#x2019;s disease (AD)-related processes, eventually resulting in mild cognitive impairment (MCI) due to AD or AD dementia (<xref ref-type="bibr" rid="B34">Mormino and Papp, 2018</xref>). The WHO reported in 2012 that about 150 million people will be impacted by dementia by 2050, with a consequent increase in the total costs of AD to over &#x0024;1 trillion (<xref ref-type="bibr" rid="B37">Patterson, 2018</xref>). Therefore, early diagnosis and prevention are critical to reduce the burdens of AD. In particular, AD prevention may be improved by identifying cognitively unimpaired (CU) individuals who are liable to progress to cognitive impairment (<xref ref-type="bibr" rid="B15">Jack et al., 2018</xref>).</p>
<p>Previous studies of early AD diagnosis were based on hypothesis-driven analyses, in which researchers classified individuals into subgroups based on their hypothesis. In contrast, in trajectory analyses, individuals are classified into distinct subgroups or classes using a data-driven classification method (<xref ref-type="bibr" rid="B36">Nguena Nguefack et al., 2020</xref>). Trajectory analyses enable researchers to better characterize and understand intra- and inter-individual variability as well as to investigate the patterns of health outcomes in longitudinal data (<xref ref-type="bibr" rid="B19">Jung and Wickrama, 2008</xref>). In this regard, mixture modeling approaches, such as growth mixture modeling (GMM) and latent class growth analysis (LCGA), have been increasingly used to identify homogeneous subpopulations within a larger heterogeneous population and to identify meaningful classes (<xref ref-type="bibr" rid="B19">Jung and Wickrama, 2008</xref>). Group-based models have been applied to patients with cognitive impairments in order to identify developmental trajectories (<xref ref-type="bibr" rid="B8">David et al., 2016</xref>; <xref ref-type="bibr" rid="B29">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="B25">Kim S. J. et al., 2022</xref>). However, there have been only a few studies applying trajectory analyses to CU individuals (<xref ref-type="bibr" rid="B40">Small and B&#x00E4;ckman, 2007</xref>; <xref ref-type="bibr" rid="B33">Min, 2018</xref>).</p>
<p>Previously, several factors have been found to influence the progression of CU to MCI or dementia (<xref ref-type="bibr" rid="B38">Rusinek et al., 2003</xref>; <xref ref-type="bibr" rid="B4">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B34">Mormino and Papp, 2018</xref>; <xref ref-type="bibr" rid="B5">Cho H. et al., 2020</xref>). Specifically, advanced age, reductions in baseline executive function, and smaller total brain volume were independently associated with the risk of conversion to MCI (<xref ref-type="bibr" rid="B4">Chen et al., 2017</xref>). In addition, CU individuals with the apolipoprotein E &#x03B5;4 allele (<italic>APOE</italic> &#x03B5;4), cerebral amyloid burdens, and cortical atrophy were more likely to progress to cognitive impairment (<xref ref-type="bibr" rid="B38">Rusinek et al., 2003</xref>; <xref ref-type="bibr" rid="B34">Mormino and Papp, 2018</xref>; <xref ref-type="bibr" rid="B5">Cho H. et al., 2020</xref>). While these study results are important, methods to translate such findings to clinical practice are needed in order to enable individualized prediction of cognitive decline.</p>
<p>As a prediction model for personalized application, the nomogram is a valuable tool. A nomogram is a chart describing the numerical relationships between diseases and risk factors and their graphical calculation (<xref ref-type="bibr" rid="B21">Kattan and Marasco, 2010</xref>). Based on the specific characteristics of patients or diseases, it is designed to help doctors and patients for risk assessment and predicting results of treatment (<xref ref-type="bibr" rid="B42">Tsikitis et al., 2016</xref>). Also, with its advantages of visual presentation and easy accessibility, nomogram can be easily used in busy clinical environments (<xref ref-type="bibr" rid="B23">Kim W. et al., 2016</xref>). Nomograms have been applied for more than a decade in oncology or cardiology. Nomograms are being developed and used more frequently in patients with cognitive deficits (<xref ref-type="bibr" rid="B18">Jang et al., 2017</xref>; <xref ref-type="bibr" rid="B24">Kim et al., 2018</xref>), but their development and application are lacking for CU individuals.</p>
<p>In the present study, we aimed to investigate the feasibilities of classification of cognitive trajectories of CU individuals in two independent cohorts with different genetic and sociocultural backgrounds. First, we determined if there were distinct growth patterns in the cognitive trajectories of the CU individuals by using mixture modeling in two independent cohorts. Second, we evaluated the features that significantly impact the classification of latent class. We hypothesized that there might be differences in the effects of features on the classification between the two datasets because participants of the two datasets have different genetic and sociocultural backgrounds. Finally, using these features, we developed a predictive model for cognitive decline in CU individuals and a nomogram to visualize risk probability.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="S2.SS1">
<title>Clinical data collection</title>
<p>We collected the data from two independent cohorts. Data used for the preparation of the current study were obtained from the ADNIMERGE dataset of the Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) database (<ext-link ext-link-type="uri" xlink:href="https://adni.loni.usc.edu">adni.loni.usc.edu</ext-link>) (<italic>n</italic> = 407) and from the Samsung Medical Center (SMC) (<italic>n</italic> = 285).</p>
<p>The ADNI was launched in 2003 as a public-private partnership, led by principal investigator Michael W. Weiner, MD. The primary purpose of the ADNI is to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical or neuropsychological assessments, can be combined to evaluate the progression of MCI and early AD. For up-to-date information, see <ext-link ext-link-type="uri" xlink:href="http://www.adni-info.org">www.adni-info.org.</ext-link> Participants from the ADNI-1 to ADNI-3 and ADNI GO were included in the current study if (1) their baseline diagnosis was CU or subjective memory complaints, (2) they had valid cognitive assessments, and (3) they had at least two follow-up assessments of cognitive function. The baseline diagnoses were determined using the standard criteria described in the ADNI procedure manuals.<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> As a result, a total of 407 individuals met these qualifications to be included in the current study. All individuals had usable neuropsychological data, and 352 individuals had hippocampal volumetric data.</p>
<p>In addition, 285 CU individuals were recruited from the SMC. These patients also had usable neuropsychological data, and 231 individuals had hippocampal volumetric data. They underwent amyloid PET scans at the SMC between September 2015 and December 2021, and were followed up at least twice through clinical interviews and thorough cognitive tests until December 2021. The following were used to establish the baseline diagnostic criteria for CU: (i) the Korean Mini-Mental State Examination (K-MMSE) &#x2265;24 or above &#x2212;1.5 SD from the age-, gender-, and education-adjusted norms if education level was &#x003C;9 years; (ii) above &#x2212;1 SD from the age-, gender-, and education-adjusted norms on the delayed recall of the Seoul Verbal Learning Test-Individuals version (SVLT-E); (iii) above &#x2212;2 SD from the age-, gender-, and education-adjusted norms on the Korean version of the Boston Naming Test (K-BNT), the Rey-Osterrieth Complex Figure Test (RCFT) copy, and the Korean Color Word Stroop Test (K-CWST) color reading; and (iv) absence of other neurological diseases.</p>
</sec>
<sec id="S2.SS2">
<title>Standard protocol approval, registration, and patient consent</title>
<p>The authors obtained approval from the ADNI Data Sharing and Publications Committee for data use and publication. No Institutional Review Board (IRB) review approval was required to use de-identified ADNI data that is available for download. All methods were carried out in accordance with the approved guidelines. At the SMC, the IRB approved the use of SMC data for this study, and all of the methods used were carried out in compliance with the approved standards.</p>
</sec>
<sec id="S2.SS3">
<title>Acquisition of neuroimaging data</title>
<p>The current study employed the following neuroimaging data from the ADNIMERGE dataset: average AV45 standardized uptake value ratios (SUVRs) of the frontal cortex, parietal cortex, anterior cingulate cortex and precuneus relative to the cerebellum, and the hippocampal volume (HV). The detailed protocols for image acquisition have been described in previous studies (<xref ref-type="bibr" rid="B16">Jagust et al., 2010</xref>) and the ADNI database.<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> Cortical reconstruction and volumetric segmentation were performed using the FreeSurfer image analysis program (<xref ref-type="bibr" rid="B13">Hartig et al., 2014</xref>).<sup><xref ref-type="fn" rid="footnote3">3</xref></sup></p>
<p>For SMC data, all individuals underwent either FBB or FMM PET scans at the SMC using a Discovery STe PET/CT scanner (GE Medical Systems, Milwaukee, WI, USA) in 3D scanning mode to examine 47 slices of 3.3-mm thickness spanning the entire brain (<xref ref-type="bibr" rid="B24">Kim et al., 2018</xref>; <xref ref-type="bibr" rid="B17">Jang et al., 2019</xref>). In our previous study, we used a direct comparison Centiloid units (dcCL) conversion equation to directly convert the SUVR values of the FBB or FMM cortical target volume of interest (CTX VOI) into dcCL units (<xref ref-type="bibr" rid="B27">Klunk et al., 2015</xref>; <xref ref-type="bibr" rid="B6">Cho S. H. et al., 2020</xref>). The conversion was performed using equations for the FBB (dcCL<sub>FBB</sub> = 151.42 &#x00D7; dcSUVR<sub>FBB</sub> &#x2212; 142.24); and the FMM (dcCL<sub>FMM</sub> = 148.52 &#x00D7; dcSUVR<sub>FMM</sub> &#x2212; 137.09) PET. All individuals also underwent 3D T1-weighted turbo field echo MRI at SMC using a 3.0-T MRI scanner (Philips 3.0T Achieva; Philips Healthcare, Andover, MA, USA) as previously described (<xref ref-type="bibr" rid="B22">Kim H. J. et al., 2016</xref>). Images were processed using the CIVET anatomical image-processing pipeline (version 2.1.0) (<xref ref-type="bibr" rid="B45">Zijdenbos et al., 2002</xref>). We calculated the intracranial volume (ICV) by measuring the total volume of the voxels within the brain mask (<xref ref-type="bibr" rid="B41">Smith, 2002</xref>). The FMRIB (Functional Magnetic Resonance Imaging of the Brain) Software Library (FSL) method was used to create brain masks. Since cortical surface models were extracted from brain MRI volumes transformed into stereotaxic space, cortical thickness was assessed in the native space by applying an inverse transformation matrix to the cortical surfaces and rebuilding them in native space (<xref ref-type="bibr" rid="B14">Im et al., 2006</xref>). To measure HV, we employed a computerized hippocampus segmentation technique that combined graph-cut optimization, atlas-based segmentation, and morphological opening (<xref ref-type="bibr" rid="B28">Kwak et al., 2013</xref>).</p>
</sec>
<sec id="S2.SS4">
<title>Neuropsychological assessments</title>
<p>The current study used the ADNI-modified Preclinical Alzheimer Cognitive Composite with the Trail-Making Test, Part B time to completion (mPACCtrt) as the cognitive endpoint from the original ADNIMERGE dataset. The PACC was developed as an outcome measure of cognitive changes in preclinical AD (<xref ref-type="bibr" rid="B11">Donohue et al., 2014</xref>). The original version includes (a) the total recall score of the Free and Cued Selective Reminding Test (FCSRT), (b) the delayed recall score of the Logical Memory IIa (LM), (c) the Digit Symbol Substitution score from the Wechsler Adult Intelligence Scale revised version (DSST), (d) Mini-Mental State Examination (MMSE) total score. Because the FCSRT was not included in the ADNI battery, the FCSRT was replaced by the delayed recall of the Alzheimer&#x2019;s Disease Assessment Scale (ADAS) in the mPACCtrt. Also, we used the Trail-Making Test, Part B (TMT-B) instead of the DSST (<xref ref-type="bibr" rid="B11">Donohue et al., 2014</xref>). As a result, the mPACCtrt consisted of (a) ADAS-cognitive subscale delayed word recall, (b) logical memory delayed recall, (c) the MMSE total score, and (d) (log-transformed) trail-making test time to completion. The composite score was the sum of the <italic>z</italic>-scores of each constituent test, which were based upon the mean and standard deviations of the baseline scores of the CU individuals in the ADNI (<xref ref-type="bibr" rid="B11">Donohue et al., 2014</xref>, <xref ref-type="bibr" rid="B10">2017</xref>).</p>
<p>For the SMC dataset, the Longitudinal Amyloid Cognitive Composite in Preclinical AD (LACPA) was used. The LACPA was developed for longitudinal tracking of amyloid-&#x03B2; (A&#x03B2;)-related cognitive decline in CU individuals using well-characterized and relatively large Korean CU cohorts (<xref ref-type="bibr" rid="B26">Kim Y. J. et al., 2022</xref>). The LACPA equation is as follows:</p>
<disp-formula id="S2.Ex1">
<mml:math id="M1">
<mml:mrow>
<mml:mpadded width="+3.3pt">
<mml:mi>LACPA</mml:mi>
</mml:mpadded>
<mml:mo rspace="5.8pt">=</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mpadded width="+3.3pt">
<mml:mi>SVLT</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+3.3pt">
<mml:mi>IR</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+3.3pt">
<mml:mi mathvariant="normal">Z</mml:mi>
</mml:mpadded>
</mml:mrow>
<mml:mo rspace="5.8pt">+</mml:mo>
<mml:mrow>
<mml:mpadded width="+3.3pt">
<mml:mi>SVLT</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+3.3pt">
<mml:mi>DR</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+3.3pt">
<mml:mi mathvariant="normal">Z</mml:mi>
</mml:mpadded>
</mml:mrow>
<mml:mo rspace="5.8pt">+</mml:mo>
<mml:mrow>
<mml:mpadded width="+2pt">
<mml:mi>SVLT</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+2pt">
<mml:mi>recognition</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mi mathvariant="normal">Z</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="S2.Ex2">
<mml:math id="M2">
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mo rspace="5.8pt">+</mml:mo>
<mml:mi mathvariant="normal">K</mml:mi>
</mml:mrow>
<mml:mo>-</mml:mo>
<mml:mi>TMT</mml:mi>
<mml:mo>-</mml:mo>
<mml:mrow>
<mml:mpadded width="+5pt">
<mml:mi mathvariant="normal">B</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+5pt">
<mml:mi>time</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+3.3pt">
<mml:mi mathvariant="normal">Z</mml:mi>
</mml:mpadded>
</mml:mrow>
</mml:mrow>
<mml:mo rspace="5.8pt">+</mml:mo>
<mml:mi mathvariant="normal">K</mml:mi>
</mml:mrow>
<mml:mo>-</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mpadded width="+2pt">
<mml:mi>MMSE</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mi mathvariant="normal">Z</mml:mi>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mpadded width="+2pt">
<mml:mi>Number</mml:mi>
</mml:mpadded>
</mml:mrow>
<mml:mo>&#x2062;</mml:mo>
<mml:mpadded width="+2pt">
<mml:mi>of</mml:mi>
</mml:mpadded>
<mml:mo>&#x2062;</mml:mo>
<mml:mi>tests</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>where IR is the immediate recall, DR is the delayed recall, K-TMT-B is the Korean Trail-Making Test Part B and Z is the <italic>z</italic>-score.</p>
</sec>
<sec id="S2.SS5">
<title>Statistical analyses</title>
<p>We used mixture modeling to test for distinct growth patterns in the cognitive trajectories of the CU individuals. Mixture modeling generally uses categorical latent variables representing the composition of a subpopulation, in which case the members of the subpopulation are unknown and inferred from the data (<xref ref-type="bibr" rid="B43">Wang and Bodner, 2007</xref>). In mixture modeling using longitudinal data, unperceived heterogeneity is captured through categorical and continuous latent variables (<xref ref-type="bibr" rid="B43">Wang and Bodner, 2007</xref>). We used mixture modeling with GMM and the LCGA for the ADNI dataset and SMC datasets, respectively. The LCGA is a special type of GMM that limits the variance and covariance estimates for growth factors within each class to zero (<xref ref-type="bibr" rid="B19">Jung and Wickrama, 2008</xref>). To determine the adequate number of latent classes, we compared the following four methods: Bayesian information criterion (BIC) (<xref ref-type="bibr" rid="B39">Schwarz, 1978</xref>); Akaike information criterion (AIC) (<xref ref-type="bibr" rid="B1">Akaike, 1974</xref>); Lo, Mendell, Rubin test (LMR) (<xref ref-type="bibr" rid="B30">Lo et al., 2001</xref>); and parametric bootstrapped likelihood ratio test (BLRT) (<xref ref-type="bibr" rid="B31">McLachlan and Peel, 2000</xref>). After determining the number of latent classes, the baseline characteristics of the latent classes were analyzed using the independent <italic>t</italic>-test and the Chi-square test.</p>
<p>To investigate the effects of variables on the cognitive trajectory group based on the mPACCtrt score derived from the ADNI dataset, we performed multivariable logistic regression analyses, which include AV45 SUVR, baseline mPACCtrt score, and HV associated with covariates including age, gender, education level, <italic>APOE</italic>&#x03B5;4. In addition, to determine the effects of variables on the cognitive trajectory group based on the LACPA score derived from the SMC dataset, we conducted multivariable logistic regression analyses, which include dcCL, baseline LACPA score, and HV associated with covariates including age, gender, education level, and <italic>APOE</italic> &#x03B5;4 (<xref ref-type="fig" rid="F1">Figure 1</xref>). The HV was used as the value divided by the ICV (HV/ICV) to consider the cranial cavity. The corrected HV was multiplied by 1,000, because of the relatively small scale. The dcCL was used as the value divided by 100.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Illustrations of the study models including predictors in the latent growth mixture modeling in <bold>(A)</bold> ADNI and <bold>(B)</bold> SMC. <sup>&#x2191;</sup>AV45 SUVR in ADNI and dcCL in SMC. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; mPACCtrt, modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B; LACPA, Longitudinal Amyloid Cognitive Composite in Preclinical AD; HV, hippocampal volume; NP, neuropsychological.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-15-1122927-g001.tif"/>
</fig>
<p>After developing the predictive models, we constructed a nomogram using the dataset. We assigned a point value to each variable using the beta coefficients from the logistic regression model. Then, the most powerful variable was set at 100 points, while other variables were assigned between 0 and 100 points based on their proportions. The total points summed by the scores corresponding to each variable were immediately converted to risk probability. Finally, the predictive accuracy of the nomogram was verified by discrimination (C-index) and calibration.</p>
<p>Mplus version 8.3 was used for the GMM, and the LCGA (<xref ref-type="bibr" rid="B35">Muth&#x00E9;n and Muth&#x00E9;n, 2019</xref>). Full information maximum likelihood (FIML) estimation was employed for the missing values found in the longitudinal data. R 4.0.3 (Vienna, Austria<sup><xref ref-type="fn" rid="footnote4">4</xref></sup>) was used for the logistic regression analyses and to develop the nomogram.</p>
</sec>
<sec id="S2.SS6">
<title>Data availability</title>
<p>The datasets used and/or analyzed during the present study are available from the corresponding authors on reasonable request.</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<sec id="S3.SS1">
<title>Demographic characteristics</title>
<p>The baseline demographic characteristics of the CU individuals included in the ADNI and SMC datasets are shown in <xref ref-type="table" rid="T1">Table 1</xref>. The mean age of the individuals was 73.2 years in the ADNI dataset and 70.7 years in the SMC dataset (<italic>p</italic> &#x003C; 0.001). The proportion of <italic>APOE</italic> &#x03B5;4 carriers was 30.2 and 29.8% in the ADNI dataset and the SMC dataset, respectively. The proportion of females was 53.8% in the ADNI dataset and 61.8% in the SMC dataset (<italic>p</italic> = 0.038).</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Baseline demographic and neuropsychological characteristics of the study participants.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Variables</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">ADNI (<italic>n</italic> = 407)</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">SMC (<italic>n</italic> = 285)</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><italic>p</italic>-Value</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years</td>
<td valign="top" align="center">73.2 &#x00B1; 6.1</td>
<td valign="top" align="center">70.7 &#x00B1; 6.9</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Education, years</td>
<td valign="top" align="center">16.6 &#x00B1; 2.6</td>
<td valign="top" align="center">11.7 &#x00B1; 4.7</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Female, <italic>N</italic> (%)</td>
<td valign="top" align="center">219 (53.8)</td>
<td valign="top" align="center">176 (61.8)</td>
<td valign="top" align="center">0.038</td>
</tr>
<tr>
<td valign="top" align="left"><italic>APOE</italic>&#x03B5;4 carrier <italic>N</italic> (%)</td>
<td valign="top" align="center">123 (30.2)</td>
<td valign="top" align="center">85 (29.8)</td>
<td valign="top" align="center">0.913</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>N</italic>, number; ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; <italic>APOE</italic>&#x03B5;4, apolipoprotein E &#x03B5;4 allele.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S3.SS2">
<title>Identifying distinguishable trajectory subgroups</title>
<p>For the ADNI dataset, to explore the number of latent class, BIC, adjusted BIC and AIC values were compared as we increased the number of classes to determine the appropriate model. Then, we compared the models using the LMR and BLRT (<xref ref-type="table" rid="T2">Table 2</xref>). Although the three-class model exhibited smaller AIC and adjusted BIC values, the two-class model had the smallest BIC value. Moreover, the difference between these values when obtained from the two- and three-class models was minimal compared to the difference for the one- and two-class models. This finding indicated that the two-class model was an appropriate model. To determine whether the two- or three-class model was better, we also used the LMR and BLRT. The LMR comparing the two- and three-class models indicated the two-class model was better (<italic>p</italic> = 0.014), and the BLRT result also supported the two-class model (<italic>p</italic> &#x003C; 0.001). Considering these results comprehensively, we decided that the two-class model would be adequate for the final model. Its entropy (the quality of the classification) was high at 0.79. For the SMC dataset, the LMR comparing the one-, two-, and three-class models indicated that the two-class model was better (<italic>p</italic> = 0.018), and the BLRT result also supported the two-class model (<italic>p</italic> &#x003C; 0.001). Considering these results comprehensively, we again decided that the two-class model would be adequate for the final model. Its entropy, the quality of the classification, was high at 0.861.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Fitting information for the growth mixture models of cognitive trajectories from the ADNI and SMC cohort datasets.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Model selection measures</td>
<td valign="top" align="center" colspan="3" style="color:#ffffff;background-color: #7f8080;">ADNI</td>
<td valign="top" align="center" colspan="3" style="color:#ffffff;background-color: #7f8080;">SMC</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>One-class</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Two-class</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Three-class</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>One-class</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Two-class</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Three-class</bold></td>
</tr>
<tr>
<td valign="top" align="left">AIC</td>
<td valign="top" align="center">8,306.216</td>
<td valign="top" align="center">8,239.018</td>
<td valign="top" align="center">8,233.775</td>
<td valign="top" align="center">2,093.981</td>
<td valign="top" align="center">1,890.766</td>
<td valign="top" align="center">1,794.979</td>
</tr>
<tr>
<td valign="top" align="left">BIC</td>
<td valign="top" align="center">8,358.331</td>
<td valign="top" align="center">8,303.159</td>
<td valign="top" align="center">8,309.942</td>
<td valign="top" align="center">2,130.506</td>
<td valign="top" align="center">1,938.248</td>
<td valign="top" align="center">1,853.419</td>
</tr>
<tr>
<td valign="top" align="left">Adjusted BIC</td>
<td valign="top" align="center">8,317.080</td>
<td valign="top" align="center">8,252.389</td>
<td valign="top" align="center">8,249.653</td>
<td valign="top" align="center">2,098.795</td>
<td valign="top" align="center">1,897.025</td>
<td valign="top" align="center">1,802.682</td>
</tr>
<tr>
<td valign="top" align="left">LMR <italic>p</italic>-value</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">0.014</td>
<td valign="top" align="center">0.449</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">0.018</td>
<td valign="top" align="center">0.050</td>
</tr>
<tr>
<td valign="top" align="left">BLRT <italic>p</italic>-value</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.066</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Entropy</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">0.790</td>
<td valign="top" align="center">0.815</td>
<td valign="top" align="center">&#x2013;</td>
<td valign="top" align="center">0.861</td>
<td valign="top" align="center">0.763</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; AIC, Akaike information criterion; BIC, Bayesian information criterion; LMR, Lo, Mendell, Rubin test; BLRT, parametric bootstrapped likelihood ratio test.</p></fn>
</table-wrap-foot>
</table-wrap>
<p><xref ref-type="fig" rid="F2">Figure 2</xref> shows the cognitive trajectories of the two-class model using the PACC and LACPA for the ADNI and SMC datasets, respectively. In the ADNI dataset, Class 1, in which the estimated class percentage was 86.2%, was a group whose cognitive function remained stable for 7 years (intercept = 0.479, SE = 0.148, <italic>p</italic> = 0.001; slope = &#x2212;0.012, SE = 0.027, <italic>p</italic> = 0.649). Class 2, in which the estimated class percentage was 13.8%, showed cognitive decline during the same period (intercept = &#x2212;1.058, SE = 0.534, <italic>p</italic> = 0.047; slope = &#x2212;1.262, SE = 0.088, <italic>p</italic> &#x003C; 0.001). Thus, we identified Class 1 a &#x201C;stable group&#x201D; and Class 2 as a &#x201C;declining group&#x201D; (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The same trajectory subgroups were also identified in CU individuals of the SMC dataset. Class 1, in which the estimated class percentage was 87.0%, was a group whose cognitive function remained stable for 7 years (intercept = 0.257, SE = 0.045, <italic>p</italic> &#x003C; 0.001; slope = &#x2212;0.060, SE = 0.023, <italic>p</italic> = 0.008). Class 2, in which the estimated class percentage was 13.0%, showed cognitive decline during the same period (intercept = &#x2212;0.734, SE = 0.180, <italic>p</italic> &#x003C; 0.001; slope = &#x2212;0.424, SE = 0.075, <italic>p</italic> &#x003C; 0.001) (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>The cognitive trajectories of the two-class model. The mPACCtrt <bold>(A)</bold> and LACPA <bold>(B)</bold> for the two-class unconditional growth mixture modeling solution. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; mPACCtrt, modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B; LACPA, Longitudinal Amyloid Cognitive Composite in Preclinical AD; <italic>N</italic>, number; yr, year.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-15-1122927-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Comparisons of the clinical characteristics of the trajectory subgroups</title>
<p>The baseline characteristics of the two trajectory groups in the ADNI dataset (351 stable and 56 decliners), and the SMC dataset (248 stable and 37 decliners) are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The data analyses indicated there were significant predictive factors among the demographic variables and biomarkers at baseline identifying individuals who were at risk of cognitive decline among the two cohorts. The mean age was higher in the decliners than in the stable groups of both datasets (<italic>t</italic>-test; ADNI <italic>p</italic> &#x003C; 0.001; SMC <italic>p</italic> = 0.032). The years of education and gender distribution did not significantly differ between the two groups. The presence of <italic>APOE</italic>&#x03B5;4 was more frequent among decliners than in the stable group (Chi-square test; ADNI <italic>p</italic> = 0.028; SMC <italic>p</italic> = 0.021). In a comparison of biomarkers including A&#x03B2; and HV, A&#x03B2; uptake was higher in the decliners than in the stable group (<italic>t</italic>-test; ADNI <italic>p</italic> &#x003C; 0.001; SMC <italic>p</italic> &#x003C; 0.001). In terms of the HV, it was lower in the decliners than in the stable group in ADNI, whereas there was no significant difference between the two groups in the SMC dataset (<italic>t</italic>-test; ADNI <italic>p</italic> &#x003C; 0.001; SMC <italic>p</italic> = 0.063). The baseline neuropsychological composite score was lower in the decliners than in the stable group in both datasets (<italic>t</italic>-test; ADNI <italic>p</italic> &#x003C; 0.001; SMC <italic>p</italic> &#x003C; 0.001).</p>
<table-wrap position="float" id="T3">
<label>TABLE 3</label>
<caption><p>Baseline demographic and neuropsychological characteristics of the individuals assigned to each latent class.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Variables</td>
<td valign="top" align="center" colspan="2" style="color:#ffffff;background-color: #7f8080;">ADNI</td>
<td valign="top" align="center" colspan="2" style="color:#ffffff;background-color: #7f8080;">SMC</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Stable (<italic>N</italic> = 351)</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Decliners (<italic>N</italic> = 56)</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Stable (<italic>N</italic> = 248)</bold></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><bold>Decliners (<italic>N</italic> = 37)</bold></td>
</tr>
<tr>
<td valign="top" align="left">Age, years<xref ref-type="table-fn" rid="t3fna"><sup>a</sup></xref></td>
<td valign="top" align="center">72.7 (6.2)</td>
<td valign="top" align="center">75.7 (5.2)<xref ref-type="table-fn" rid="t3fns1">&#x002A;</xref></td>
<td valign="top" align="center">70.4 (7.0)</td>
<td valign="top" align="center">73.0 (6.0)<xref ref-type="table-fn" rid="t3fns1">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">Education, years<xref ref-type="table-fn" rid="t3fna"><sup>a</sup></xref></td>
<td valign="top" align="center">16.6 (2.6)</td>
<td valign="top" align="center">16.5 (2.4)</td>
<td valign="top" align="center">11.6 (4.6)</td>
<td valign="top" align="center">12.2 (5.0)</td>
</tr>
<tr>
<td valign="top" align="left">Female, <italic>N</italic> (%)</td>
<td valign="top" align="center">189 (53.8)</td>
<td valign="top" align="center">30 (53.6)</td>
<td valign="top" align="center">152 (61.3)</td>
<td valign="top" align="center">24 (64.9)</td>
</tr>
<tr>
<td valign="top" align="left"><italic>APOE</italic>&#x03B5;4 carrier <italic>N</italic> (%)</td>
<td valign="top" align="center">99 (28.3)</td>
<td valign="top" align="center">24 (42.9)<xref ref-type="table-fn" rid="t3fns1">&#x002A;</xref></td>
<td valign="top" align="center">68 (28.2)</td>
<td valign="top" align="center">17 (47.2)<xref ref-type="table-fn" rid="t3fns1">&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">A&#x03B2; uptake<sup>a&#x2191;</sup></td>
<td valign="top" align="center">1.1 (0.2)</td>
<td valign="top" align="center">1.3 (0.2)<xref ref-type="table-fn" rid="t3fns1">&#x002A;&#x002A;</xref></td>
<td valign="top" align="center">24.9 (39.0)</td>
<td valign="top" align="center">57.5 (48.7)<xref ref-type="table-fn" rid="t3fns1">&#x002A;&#x002A;</xref></td>
</tr>
<tr>
<td valign="top" align="left">HV/ICV<xref ref-type="table-fn" rid="t3fna"><sup>a</sup></xref></td>
<td valign="top" align="center">5.0 &#x00D7; 10<sup>&#x2013;3</sup> (6.3 &#x00D7; 10<sup>&#x2013;4</sup>)</td>
<td valign="top" align="center">4.6 &#x00D7; 10<sup>&#x2013;3</sup> (6.7 &#x00D7; 10<sup>&#x2013;4</sup>)<sup>&#x002A;&#x002A;</sup></td>
<td valign="top" align="center">2.3 &#x00D7; 10<sup>&#x2013;3</sup> (3.2 &#x00D7; 10<sup>&#x2013;4</sup>)</td>
<td valign="top" align="center">2.2 &#x00D7; 10<sup>&#x2013;3</sup> (2.9 &#x00D7; 10<sup>&#x2013;4</sup>)</td>
</tr>
<tr>
<td valign="top" align="left">Baseline neuropsychological composite score<sup>a&#x2191;&#x2191;</sup></td>
<td valign="top" align="center">0.36 (2.45)</td>
<td valign="top" align="center">&#x2212;1.84 (2.81)<xref ref-type="table-fn" rid="t3fns1">&#x002A;&#x002A;</xref></td>
<td valign="top" align="center">0.25 (0.52)</td>
<td valign="top" align="center"><sup>&#x2013;</sup>0.75 (0.62)<xref ref-type="table-fn" rid="t3fns1">&#x002A;&#x002A;</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t3fns1"><p>&#x002A;<italic>p</italic> &#x003C; 0.05; &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.001.</p></fn>
<fn id="t3fna"><p><sup>a</sup>Values are the mean and SD. <sup>&#x2191;</sup>AV45 SUVR in ADNI and dcCL in SMC. <sup>&#x2191;&#x2191;</sup>Modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B in the ADNI cohort, Longitudinal Amyloid Cognitive Composite in Preclinical AD in the SMC cohort. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; <italic>APOE</italic>&#x03B5;4, apolipoprotein E &#x03B5;4 allele; A&#x03B2;, amyloid-&#x03B2;; SUVR, standardized uptake value ratio; dcCL, direct comparison Centiloid units; HV, hippocampal volume; ICV: intracranial volume.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S3.SS4">
<title>Development of the predictive model</title>
<p>Multivariable logistic regression was used to analyze the associations between cognitive decline and potential predictors. <xref ref-type="table" rid="T4">Table 4</xref> shows the significant measures predicting cognitive decline. In the model using the ADNI dataset, the multivariable logistic regression model showed that A&#x03B2; uptake, baseline neuropsychological composite score and HV were predictive of being included in the cognitive decline group. Increased A&#x03B2; uptake (&#x03B2; [SE]: 4.852 [0.862], <italic>p</italic> &#x003C; 0.001), lower baseline neuropsychological composite score (&#x03B2; [SE]: &#x2212;0.274 [0.070], <italic>p</italic> &#x003C; 0.001), and lower HV (&#x03B2; [SE]: &#x2212;0.952 [0.302], <italic>p</italic> = 0.002) were significantly correlated with greater likelihood of being included in the cognitive decline group. The predictive performance (C-index) in the ADNI model was 0.85 (<xref ref-type="table" rid="T4">Table 4</xref>). In the model using the SMC dataset increased A&#x03B2; uptake (&#x03B2; [SE]: 2.007 [0.549], <italic>p</italic> = 0.007) and lower baseline neuropsychological composite scores (&#x03B2; [SE]: &#x2212;4.464 [0.758] <italic>p</italic> &#x003C; 0.001) were significantly correlated with greater risk probability. The C-index in the SMC model was 0.94. In addition, gender (&#x03B2; [SE]: 0.517 [0.386], <italic>p</italic> = 0.180) in ADNI data, age (&#x03B2; [SE]: 0.081 [0.039], <italic>p</italic> = 0.038) and gender (&#x03B2; [SE]: 1.093 [0.532], <italic>p</italic> = 0.040) in SMC data were also statistically significant variables when the <italic>p</italic>-value is based on 0.2, although the statistical significance is lower than other variables (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
<table-wrap position="float" id="T4">
<label>TABLE 4</label>
<caption><p>Multivariable logistic regression for the predictive model.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;"></td>
<td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;">Predictors</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><italic>B</italic></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">SE</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">OR</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">95% CI</td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;"><italic>p</italic></td>
<td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;">C-index</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">ADNI</td>
<td valign="top" align="left">Intercept</td>
<td valign="top" align="center">-3.311</td>
<td valign="top" align="center">1.724</td>
<td valign="top" align="center">0.036</td>
<td valign="top" align="center">&#x2212;</td>
<td valign="top" align="center">0.055</td>
<td valign="top" align="center">0.854</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Female</td>
<td valign="top" align="center">0.517</td>
<td valign="top" align="center">0.386</td>
<td valign="top" align="center">1.678</td>
<td valign="top" align="center">0.788, 3.574</td>
<td valign="top" align="center">0.180</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">A&#x03B2; uptake<sup>&#x2191;</sup></td>
<td valign="top" align="center">4.852</td>
<td valign="top" align="center">0.862</td>
<td valign="top" align="center">128.013</td>
<td valign="top" align="center">23.628, 693.563</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">HV/ICV</td>
<td valign="top" align="center">-0.952</td>
<td valign="top" align="center">0.302</td>
<td valign="top" align="center">0.386</td>
<td valign="top" align="center">0.214, 0.697</td>
<td valign="top" align="center">0.002</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">Baseline neuropsychological composite score<sup>&#x2191;&#x2191;</sup></td>
<td valign="top" align="center">-0.274</td>
<td valign="top" align="center">0.070</td>
<td valign="top" align="center">0.760</td>
<td valign="top" align="center">0.663, 0.872</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">SMC</td>
<td valign="top" align="left">Intercept</td>
<td valign="top" align="center">-10.281</td>
<td valign="top" align="center">3.017</td>
<td valign="top" align="center">3.4 &#x00D7; 10<sup>&#x2013;5</sup></td>
<td valign="top" align="center">&#x2212;</td>
<td valign="top" align="center">0.001</td>
<td valign="top" align="center">0.941</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Age</td>
<td valign="top" align="center">0.081</td>
<td valign="top" align="center">0.039</td>
<td valign="top" align="center">1.084</td>
<td valign="top" align="center">1.004, 1.171</td>
<td valign="top" align="center">0.038</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">Female</td>
<td valign="top" align="left">1.093</td>
<td valign="top" align="center">0.532</td>
<td valign="top" align="center">2.983</td>
<td valign="top" align="center">1.052, 8.464</td>
<td valign="top" align="center">0.040</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">A&#x03B2; uptake (CL)<sup>&#x2191;</sup></td>
<td valign="top" align="left">2.007</td>
<td valign="top" align="center">0.549</td>
<td valign="top" align="center">7.438</td>
<td valign="top" align="center">2.536, 21.817</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">Baseline neuropsychological composite score<sup>&#x2191;&#x2191;</sup></td>
<td valign="top" align="left">-4.464</td>
<td valign="top" align="center">0.758</td>
<td valign="top" align="center">0.012</td>
<td valign="top" align="center">0.003, 0.051</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><sup>&#x2191;</sup>AV45 SUVR in ADNI and dcCL in SMC. <sup>&#x2191;&#x2191;</sup>Modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B in ADNI cohort, Longitudinal Amyloid Cognitive Composite in Preclinical AD in SMC cohort. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; A&#x03B2;, amyloid-&#x03B2;; SUVR, standardized uptake value ratio; dcCL, direct comparison Centiloid units; HV, hippocampal volume; ICV, intracranial volume; SE, standard error; OR, odds ratio; 95% CI, 95% confidence interval.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>We then constructed nomograms based on the multivariable logistic regression results (<xref ref-type="fig" rid="F3">Figure 3</xref>). The total points were calculated from the sum of each point, and the risk probability was calculated from the total points. The probability in our nomograms referred to risk probability of being assigned to a cognitive decline group. The bias-corrected calibrated values were generated from validations based on 1,000 bootstrap resamples. The non-parametric calibration curves revealed that the bias-corrected calibration plots were close to the 45&#x00B0; line, indicating the nomograms are well calibrated (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Nomograms predicting the cognitive decline of the cognitively unimpaired individuals in <bold>(A)</bold> ADNI and <bold>(B)</bold> SMC. Age (only in SMC), gender, amyloid uptake, hippocampal volume (only in ADNI), and baseline neuropsychological composite score are variables that significantly and independently affected the cognitive trajectory of the cognitively unimpaired individuals. Using odd ratios from the regression model, each variable was assigned points. The total points from all variables indicated the probability of the declining group in the nomogram. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center; SUVR: standardized uptake value ratio; dcCL: direct comparison Centiloid units; HV, hippocampal volume; ICV, intracranial volume; mPACCtrt, modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B; LACPA, Longitudinal Amyloid Cognitive Composite in Preclinical AD.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-15-1122927-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS5">
<title>Visualization of the predictive model</title>
<p>Finally, we visualized the risk score of each predictor and the predicted probability of belonging to a trajectory group using the predictive model (<xref ref-type="fig" rid="F4">Figure 4</xref>). Specifically, for a woman with an AV45 SUVR of 1.5, HV/ICV of 0.004 and an mPACCtrt of &#x2212;2, the risk scores of all predictors are 142, so the probability of belonging to the declining group was estimated to be 77.2%.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Example of the graphical representation of the model predictors. The subject was a woman with an AV45 SUVR of 1.5, HV/ICV of 0.004, and an mPACCtrt of &#x2013;2. As a result, her total score was 142 and the model predicted her corresponding probability of cognitive decline would be 77.2%. SUVR, standardized uptake value ratio; HV, hippocampal volume; ICV, intracranial volume; mPACCtrt, modified Preclinical Alzheimer&#x2019;s Cognitive Composite with Trail-Making Test, Part B.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnagi-15-1122927-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we explored the cognitive trajectories of CU individuals in two independent cohorts identified from the ADNI and SMC datasets. Our major findings were as follows. First, 13.8% of the CU individuals in the ADNI dataset were classified in the declining group, which was similar to the proportion of the decliners in the SMC dataset. Second, increased amyloid uptake, lower baseline neuropsychological composite score, and decreased HV (only in ADNI) were predictive of being classified within the declining group. Finally, predictive models of cognitive decline showed fair to good discrimination and calibration capabilities. Taken together, our analysis provided novel insights into the different cognitive trajectories of CU individuals. Furthermore, the predictive model may facilitate the classification of CU individuals, and could be employed in future primary prevention trials.</p>
<p>Our first major finding was that 13.8% of the CU individuals in the ADNI dataset were classified to the declining group, similar to the results for the SMC dataset. Regarding the conversion from CU to MCI, a previous study revealed that clinic-based sample populations demonstrated an annual conversion rate of 30% (95% CI 17&#x2013;54%) per person-year, and the community-based sample population demonstrated a conversion rate of 5% (95% CI 3&#x2013;6%) per person-year (<xref ref-type="bibr" rid="B4">Chen et al., 2017</xref>). In another study, 6.7% of CU individuals converted to MCI within a mean of 13.1 months (<xref ref-type="bibr" rid="B12">Fernandez-Blazquez et al., 2016</xref>). While previous studies used the binary classification of conversion of CU to MCI, our study employed a data-driven classification to the CU based on longitudinal cognitive performance rather than on <italic>a priori</italic> classifications. A previous study using the mixture modeling showed that 6.7% of CU were classified into the declining group (<xref ref-type="bibr" rid="B33">Min, 2018</xref>). This discrepancy might be explained by the differences in neuropsychological test measurements between the previous study and our study. Previous studies used the MMSE (<xref ref-type="bibr" rid="B40">Small and B&#x00E4;ckman, 2007</xref>; <xref ref-type="bibr" rid="B33">Min, 2018</xref>), and this measure may not be sensitive enough to detect subtle cognitive changes in CU. However, our study used cognitive composites that are sensitive enough to detect subtle cognitive changes in CU, such as the PACC for the ADNI dataset and the LACPA for the SMC dataset. These two composite scores assess episodic memory, executive function, and global cognition (<xref ref-type="bibr" rid="B11">Donohue et al., 2014</xref>; <xref ref-type="bibr" rid="B26">Kim Y. J. et al., 2022</xref>) and have been frequently used to track cognitive changes in CU individuals (<xref ref-type="bibr" rid="B11">Donohue et al., 2014</xref>; <xref ref-type="bibr" rid="B26">Kim Y. J. et al., 2022</xref>).</p>
<p>Our second major finding was that increased A&#x03B2; uptake, decreased neuropsychological composite scores and decreased HV (only in ADNI) in individuals were predictive of being assigned to the declining group. Our findings are consistent with converging evidence. Specifically, a previous study suggested that cognitive performance, <italic>APOE</italic> &#x03B5;4, decreased hippocampal and entorhinal cortex volumes, and increased cerebrospinal fluid p-tau were the most feasible predictors of CU to MCI conversion within 5 years (<xref ref-type="bibr" rid="B2">Albert et al., 2018</xref>). Therefore, the detection of these predictors in CU individuals has provided an important opportunity to understanding the contributions of these predictors to cognitive decline (<xref ref-type="bibr" rid="B34">Mormino and Papp, 2018</xref>).</p>
<p>Notably, there were some differences between the ADNI and SMC datasets with respect to the relative effects of each predictor. Specifically, relative to the ADNI dataset, the SMC dataset showed greater relative effects of females on the faster decliner. Previous studies indicated that females showed faster cognitive decline than males. Considering that the ADNI and SMC datasets include mainly non-Hispanic Whites (NHW) and Koreans, respectively, it might be related to the interactive effects of ethnicity and gender on cognitive decline. Although the underlying mechanisms are not fully understood, these gender- and ethnicity-specific differences might be related to genetic and sociocultural differences between Korean and NHW participants. In fact, a previous study from our group suggested that females suffered more deleterious effects of cardiometabolic syndrome on brain aging than males, which is more pronounced in Koreans than in UKs (<xref ref-type="bibr" rid="B20">Kang et al., 2022</xref>). Also, relative to the ADNI dataset, the SMC dataset showed greater relative effects of decreased neuropsychological composite scores than increased A&#x03B2; uptake and decreased HV. Further studies are needed to determine whether ethnicity influences Alzheimer&#x2019;s pathology and progression.</p>
<p>Our final major finding was that predictive models of cognitive decline in CU individuals revealed fair to good discrimination and calibration capabilities. Previously, there were few predictive models for CU to MCI conversion. Nevertheless, previous studies have shown that the conversion of CU to MCI is influenced by fixed time and cognitive impairment levels. Our study&#x2019;s contribution is the development of a model that can predict and visualize the individual risk of cognitive decline regardless of fixed time and set cognitive impairment levels. Furthermore, in the present study, visualization was performed by utilizing the nomogram to assess the predicted probability of a trajectory subgroup. As a result, our model may be able to produce clinically useful results allowing for a more clear interpretation. This model could facilitate identification of individuals who are at risk of cognitive decline.</p>
<p>The strength of the present study was that we developed predictive models based on two independent cohorts with multimodal imaging markers and by using a sophisticated GMM method. However, there are several issues that should be discussed. First, we did not include longitudinal changes in HV and A&#x03B2; in our model. Future studies are needed to determine whether incorporating longitudinal changes in HV and A&#x03B2; might increase prediction accuracy. In addition, since GMM estimates all variances, convergence errors can occur (<xref ref-type="bibr" rid="B32">McNeish et al., 2021</xref>). Nomograms assume that outcomes remain constant over time, and can become less accurate over time for a variety of reasons, such as improvements in earlier detection and management (<xref ref-type="bibr" rid="B3">Balachandran et al., 2015</xref>). Finally, other pathologies such as tau, argyrophilic grain disease, Lewy body disease, transactive response DNA-binding protein (TDP-43) pathology, hippocampal sclerosis, atherosclerosis, and gross infarcts that are associated with global cognitive decline were not considered (<xref ref-type="bibr" rid="B44">Wilson et al., 2020</xref>). Overall, despite these limitations, our study is unique in that it focuses on the cognitive trajectory of CU individuals and provides useful predictive models to identify CU individuals who may show future cognitive decline.</p>
</sec>
<sec id="S5" sec-type="conclusion">
<title>Conclusion</title>
<p>In conclusion, our study provides novel insights into different cognitive trajectories among CU individuals. Since the predictive model was able to classify CU individuals with respect to potential future cognitive decline, this model could be employed in future primary AD prevention trials.</p>
</sec>
<sec id="S6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="S7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Institutional Review Board of Samsung Medical Center. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="S8" sec-type="author-contributions">
<title>Author contributions</title>
<p>YK: conceptualization, formal analysis, methodology, resources, writing&#x2014;original draft, and writing&#x2014;review and editing. SK and AH: conceptualization, methodology, resources, writing&#x2014;original draft, and writing&#x2014;review and editing. HJ and JK: methodology, resources, and writing&#x2014;review and editing. HK and DN: conceptualization, resources, and writing&#x2014;review and editing. JC: conceptualization, resources, supervision, and writing&#x2014;review and editing. SS: conceptualization, funding acquisition (lead), resources, supervision (lead), and writing&#x2014;review and editing. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="S9" sec-type="funding-information">
<title>Funding</title>
<p>This research was supported by a grant of the Korea Health Technology R&#x0026;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &#x0026; Welfare and Ministry of Science and ICT, Republic of Korea (HI19C1132, HU20C0111, and HU22C0170), the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIT) (NRF-2019R1A5A2027340), Institute of Information &#x0026; Communications Technology Planning &#x0026; Evaluation (IITP) grant funded by the Korea Government (MSIT) (No. 2021-0-02068, Artificial Intelligence Innovation Hub), Future Medicine 20&#x002A;30 Project of the Samsung Medical Center (#SMX1230081), and the &#x201C;National Institutes of Health&#x201D; Research Project (2021-ER1006-02).</p>
</sec>
<sec id="S10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnagi.2023.1122927/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnagi.2023.1122927/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.JPEG" id="FS1" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 1</label>
<caption><p>Bootstrap calibration curve for the ADNI <bold>(A)</bold> and SMC <bold>(B)</bold> models, showing the validation results in terms of discrimination capabilities. Dotted line, apparent calibration accuracy; solid line, bias-corrected calibration curve; and dashed line, ideal calibration. This model is well calibrated, because the bias-corrected calibration plot is close to the 45&#x00B0; line. ADNI, Alzheimer&#x2019;s Disease Neuroimaging Initiative; SMC, Samsung Medical Center.</p></caption>
</supplementary-material>
</sec>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.adni-info.org">www.adni-info.org</ext-link></p></fn>
<fn id="footnote2">
<label>2</label>
<p><ext-link ext-link-type="uri" xlink:href="http://adni.loni.usc.edu">adni.loni.usc.edu</ext-link></p></fn>
<fn id="footnote3">
<label>3</label>
<p><ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu/">http://surfer.nmr.mgh.harvard.edu/</ext-link></p></fn>
<fn id="footnote4">
<label>4</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link></p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akaike</surname> <given-names>H.</given-names></name></person-group> (<year>1974</year>). <article-title>A new look at the statistical model identification.</article-title> <source><italic>IEEE Trans. Autom. Control</italic></source> <volume>19</volume> <fpage>716</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1109/TAC.1974.1100705</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname> <given-names>M.</given-names></name> <name><surname>Zhu</surname> <given-names>Y.</given-names></name> <name><surname>Moghekar</surname> <given-names>A.</given-names></name> <name><surname>Mori</surname> <given-names>S.</given-names></name> <name><surname>Miller</surname> <given-names>M. I.</given-names></name> <name><surname>Soldan</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years.</article-title> <source><italic>Brain</italic></source> <volume>141</volume> <fpage>877</fpage>&#x2013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awx365</pub-id> <pub-id pub-id-type="pmid">29365053</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname> <given-names>V. P.</given-names></name> <name><surname>Gonen</surname> <given-names>M.</given-names></name> <name><surname>Smith</surname> <given-names>J. J.</given-names></name> <name><surname>DeMatteo</surname> <given-names>R. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Nomograms in oncology: more than meets the eye.</article-title> <source><italic>Lancet Oncol.</italic></source> <volume>16</volume> <fpage>e173</fpage>&#x2013;<lpage>e180</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(14)71116-7</pub-id> <pub-id pub-id-type="pmid">25846097</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Denny</surname> <given-names>K. G.</given-names></name> <name><surname>Harvey</surname> <given-names>D.</given-names></name> <name><surname>Farias</surname> <given-names>S. T.</given-names></name> <name><surname>Mungas</surname> <given-names>D.</given-names></name> <name><surname>DeCarli</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.</article-title> <source><italic>Alzheimers Dement.</italic></source> <volume>13</volume> <fpage>399</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2016.07.151</pub-id> <pub-id pub-id-type="pmid">27590706</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>H.</given-names></name> <name><surname>Kim</surname> <given-names>Y.-E.</given-names></name> <name><surname>Chae</surname> <given-names>W.</given-names></name> <name><surname>Kim</surname> <given-names>K. W.</given-names></name> <name><surname>Kim</surname> <given-names>J.-W.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>10</volume>:<issue>13365</issue>. <pub-id pub-id-type="doi">10.1038/s41598-020-69603-w</pub-id> <pub-id pub-id-type="pmid">32770103</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>S. H.</given-names></name> <name><surname>Choe</surname> <given-names>Y. S.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Kim</surname> <given-names>Y.</given-names></name> <name><surname>Kim</surname> <given-names>S. E.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A new Centiloid method for (18)F-florbetaben and (18)F-flutemetamol PET without conversion to PiB.</article-title> <source><italic>Eur. J. Nucl. Med. Mol. Imaging</italic></source> <volume>47</volume> <fpage>1938</fpage>&#x2013;<lpage>1948</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-019-04596-x</pub-id> <pub-id pub-id-type="pmid">31834446</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><collab>Committee on the Public Health Dimensions of Cognitive Aging, Board on Health Sciences Policy, and Institute of Medicine</collab> (<year>2015</year>). &#x201C;<article-title>The National academies collection: reports funded by National Institutes of Health</article-title>,&#x201D; in <source><italic>Cognitive Aging: Progress in Understanding and Opportunities for Action</italic></source>, <role>eds</role> <person-group person-group-type="editor"><name><surname>Blazer</surname> <given-names>D. G.</given-names></name> <name><surname>Yaffe</surname> <given-names>K.</given-names></name> <name><surname>Liverman</surname> <given-names>C. T.</given-names></name></person-group> (<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>).</citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>N. D.</given-names></name> <name><surname>Lin</surname> <given-names>F.</given-names></name> <name><surname>Porsteinsson</surname> <given-names>A. P.</given-names></name></person-group> <collab>Alzheimer&#x2019;s Disease Neuroimaging Initiative</collab> (<year>2016</year>). <article-title>Trajectories of neuropsychiatric symptoms and cognitive decline in mild cognitive impairment.</article-title> <source><italic>Am. J. Geriatr. Psychiatry</italic></source> <volume>24</volume> <fpage>70</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.jagp.2015.06.001</pub-id> <pub-id pub-id-type="pmid">26525995</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deary</surname> <given-names>I. J.</given-names></name> <name><surname>Corley</surname> <given-names>J.</given-names></name> <name><surname>Gow</surname> <given-names>A. J.</given-names></name> <name><surname>Harris</surname> <given-names>S. E.</given-names></name> <name><surname>Houlihan</surname> <given-names>L. M.</given-names></name> <name><surname>Marioni</surname> <given-names>R. E.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Age-associated cognitive decline.</article-title> <source><italic>Br. Med. Bull.</italic></source> <volume>92</volume> <fpage>135</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1093/bmb/ldp033</pub-id> <pub-id pub-id-type="pmid">19776035</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donohue</surname> <given-names>M. C.</given-names></name> <name><surname>Sperling</surname> <given-names>R. A.</given-names></name> <name><surname>Petersen</surname> <given-names>R.</given-names></name> <name><surname>Sun</surname> <given-names>C. K.</given-names></name> <name><surname>Weiner</surname> <given-names>M. W.</given-names></name> <name><surname>Aisen</surname> <given-names>P. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons.</article-title> <source><italic>JAMA</italic></source> <volume>317</volume> <fpage>2305</fpage>&#x2013;<lpage>2316</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.6669</pub-id> <pub-id pub-id-type="pmid">28609533</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donohue</surname> <given-names>M. C.</given-names></name> <name><surname>Sperling</surname> <given-names>R. A.</given-names></name> <name><surname>Salmon</surname> <given-names>D. P.</given-names></name> <name><surname>Rentz</surname> <given-names>D. M.</given-names></name> <name><surname>Raman</surname> <given-names>R.</given-names></name> <name><surname>Thomas</surname> <given-names>R. G.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.</article-title> <source><italic>JAMA Neurol.</italic></source> <volume>71</volume> <fpage>961</fpage>&#x2013;<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2014.803</pub-id> <pub-id pub-id-type="pmid">24886908</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Blazquez</surname> <given-names>M. A.</given-names></name> <name><surname>Avila-Villanueva</surname> <given-names>M.</given-names></name> <name><surname>Maestu</surname> <given-names>F.</given-names></name> <name><surname>Medina</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Specific features of subjective cognitive decline predict faster conversion to mild cognitive impairment.</article-title> <source><italic>J. Alzheimers Dis.</italic></source> <volume>52</volume> <fpage>271</fpage>&#x2013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150956</pub-id> <pub-id pub-id-type="pmid">27060949</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartig</surname> <given-names>M.</given-names></name> <name><surname>Truran-Sacrey</surname> <given-names>D.</given-names></name> <name><surname>Raptentsetsang</surname> <given-names>S.</given-names></name> <name><surname>Simonson</surname> <given-names>A.</given-names></name> <name><surname>Mezher</surname> <given-names>A.</given-names></name> <name><surname>Schuff</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <source><italic>UCSF FreeSurfer Methods.</italic></source> <publisher-loc>Chicago, IL</publisher-loc>: <publisher-name>Alzheimer&#x2019;s Association</publisher-name>.</citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Im</surname> <given-names>K.</given-names></name> <name><surname>Lee</surname> <given-names>J.-M.</given-names></name> <name><surname>Lee</surname> <given-names>J.</given-names></name> <name><surname>Shin</surname> <given-names>Y.-W.</given-names></name> <name><surname>Kim</surname> <given-names>I. Y.</given-names></name> <name><surname>Kwon</surname> <given-names>J. S.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Gender difference analysis of cortical thickness in healthy young adults with surface-based methods.</article-title> <source><italic>NeuroImage</italic></source> <volume>31</volume> <fpage>31</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.11.042</pub-id> <pub-id pub-id-type="pmid">16426865</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname> <given-names>C. R.</given-names> <suffix>Jr.</suffix></name> <name><surname>Bennett</surname> <given-names>D. A.</given-names></name> <name><surname>Blennow</surname> <given-names>K.</given-names></name> <name><surname>Carrillo</surname> <given-names>M. C.</given-names></name> <name><surname>Dunn</surname> <given-names>B.</given-names></name> <name><surname>Haeberlein</surname> <given-names>S. B.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>NIA-AA Research framework: toward a biological definition of Alzheimer&#x2019;s disease.</article-title> <source><italic>Alzheimers Dement.</italic></source> <volume>14</volume> <fpage>535</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2018.02.018</pub-id> <pub-id pub-id-type="pmid">29653606</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jagust</surname> <given-names>W. J.</given-names></name> <name><surname>Bandy</surname> <given-names>D.</given-names></name> <name><surname>Chen</surname> <given-names>K.</given-names></name> <name><surname>Foster</surname> <given-names>N. L.</given-names></name> <name><surname>Landau</surname> <given-names>S. M.</given-names></name> <name><surname>Mathis</surname> <given-names>C. A.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>The Alzheimer&#x2019;s Disease Neuroimaging Initiative positron emission tomography core.</article-title> <source><italic>Alzheimers Dement.</italic></source> <volume>6</volume> <fpage>221</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2010.03.003</pub-id> <pub-id pub-id-type="pmid">20451870</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Jang</surname> <given-names>Y. K.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Werring</surname> <given-names>D. J.</given-names></name> <name><surname>Lee</surname> <given-names>J. S.</given-names></name> <name><surname>Choe</surname> <given-names>Y. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Clinical significance of amyloid beta positivity in patients with probable cerebral amyloid angiopathy markers.</article-title> <source><italic>Eur. J. Nucl. Med. Mol. Imaging</italic></source> <volume>46</volume> <fpage>1287</fpage>&#x2013;<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-019-04314-7</pub-id> <pub-id pub-id-type="pmid">30937462</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Ye</surname> <given-names>B. S.</given-names></name> <name><surname>Woo</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>S. W.</given-names></name> <name><surname>Chin</surname> <given-names>J.</given-names></name> <name><surname>Choi</surname> <given-names>S. H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Prediction model of conversion to dementia risk in subjects with amnestic mild cognitive impairment: a longitudinal, multi-center clinic-based study.</article-title> <source><italic>J. Alzheimers Dis.</italic></source> <volume>60</volume> <fpage>1579</fpage>&#x2013;<lpage>1587</lpage>. <pub-id pub-id-type="doi">10.3233/jad-170507</pub-id> <pub-id pub-id-type="pmid">28968237</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>T.</given-names></name> <name><surname>Wickrama</surname> <given-names>K. A. S.</given-names></name></person-group> (<year>2008</year>). <article-title>An introduction to latent class growth analysis and growth mixture modeling.</article-title> <source><italic>Soc. Pers. Psychol. Compass</italic></source> <volume>2</volume> <fpage>302</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-9004.2007.00054.x</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>S. H.</given-names></name> <name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Seo</surname> <given-names>S. W.</given-names></name> <name><surname>Kim</surname> <given-names>H.</given-names></name></person-group> (<year>2022</year>). <source><italic>Differential Effects of Cardiometabolic Syndrome on Brain Age in Relation to Sex and Ethnicity.</italic></source> <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>CTAD22</publisher-name>.</citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kattan</surname> <given-names>M. W.</given-names></name> <name><surname>Marasco</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>What is a real nomogram?</article-title> <source><italic>Semin. Oncol.</italic></source> <volume>37</volume> <fpage>23</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1053/j.seminoncol.2009.12.003</pub-id> <pub-id pub-id-type="pmid">20172360</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Yang</surname> <given-names>J. J.</given-names></name> <name><surname>Kwon</surname> <given-names>H.</given-names></name> <name><surname>Kim</surname> <given-names>C.</given-names></name> <name><surname>Lee</surname> <given-names>J. M.</given-names></name> <name><surname>Chun</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Relative impact of amyloid-beta, lacunes, and downstream imaging markers on cognitive trajectories.</article-title> <source><italic>Brain</italic></source> <volume>139</volume>(<issue>Pt 9</issue>), <fpage>2516</fpage>&#x2013;<lpage>2527</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww148</pub-id> <pub-id pub-id-type="pmid">27329772</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>W.</given-names></name> <name><surname>Kim</surname> <given-names>K. S.</given-names></name> <name><surname>Park</surname> <given-names>R. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Nomogram of naive bayesian model for recurrence prediction of breast cancer.</article-title> <source><italic>Healthc. Inform. Res.</italic></source> <volume>22</volume> <fpage>89</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.4258/hir.2016.22.2.89</pub-id> <pub-id pub-id-type="pmid">27200218</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. E.</given-names></name> <name><surname>Woo</surname> <given-names>S.</given-names></name> <name><surname>Kim</surname> <given-names>S. W.</given-names></name> <name><surname>Chin</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Lee</surname> <given-names>B. I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>A nomogram for predicting amyloid PET positivity in amnestic mild cognitive impairment.</article-title> <source><italic>J. Alzheimers Dis.</italic></source> <volume>66</volume> <fpage>681</fpage>&#x2013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.3233/jad-180048</pub-id> <pub-id pub-id-type="pmid">30320571</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. J.</given-names></name> <name><surname>Woo</surname> <given-names>S. Y.</given-names></name> <name><surname>Kim</surname> <given-names>Y. J.</given-names></name> <name><surname>Jang</surname> <given-names>H.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Na</surname> <given-names>D. L.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.</article-title> <source><italic>Neurobiol. Aging</italic></source> <volume>114</volume> <fpage>84</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2022.02.012</pub-id> <pub-id pub-id-type="pmid">35341619</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>Y. J.</given-names></name> <name><surname>Hahn</surname> <given-names>A.</given-names></name> <name><surname>Park</surname> <given-names>Y. H.</given-names></name> <name><surname>Na</surname> <given-names>D. L.</given-names></name> <name><surname>Chin</surname> <given-names>J.</given-names></name> <name><surname>Seo</surname> <given-names>S. W.</given-names></name></person-group> (<year>2022</year>). <article-title>Longitudinal amyloid cognitive composite in preclinical Alzheimer&#x2019;s disease.</article-title> <source><italic>Eur. J. Neurol.</italic></source> <volume>29</volume> <fpage>980</fpage>&#x2013;<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1111/ene.15241</pub-id> <pub-id pub-id-type="pmid">34972256</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klunk</surname> <given-names>W. E.</given-names></name> <name><surname>Koeppe</surname> <given-names>R. A.</given-names></name> <name><surname>Price</surname> <given-names>J. C.</given-names></name> <name><surname>Benzinger</surname> <given-names>T. L.</given-names></name> <name><surname>Devous</surname> <given-names>M. D.</given-names> <suffix>Sr.</suffix></name> <name><surname>Jagust</surname> <given-names>W. J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The centiloid project: standardizing quantitative amyloid plaque estimation by PET.</article-title> <source><italic>Alzheimers Dement.</italic></source> <volume>11</volume> <fpage>1</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2014.07.003</pub-id> <pub-id pub-id-type="pmid">25443857</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname> <given-names>K.</given-names></name> <name><surname>Yoon</surname> <given-names>U.</given-names></name> <name><surname>Lee</surname> <given-names>D.-K.</given-names></name> <name><surname>Kim</surname> <given-names>G. H.</given-names></name> <name><surname>Seo</surname> <given-names>S. W.</given-names></name> <name><surname>Na</surname> <given-names>D. L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Fully-automated approach to hippocampus segmentation using a graph-cuts algorithm combined with atlas-based segmentation and morphological opening.</article-title> <source><italic>Magn. Resonan. Imaging</italic></source> <volume>31</volume> <fpage>1190</fpage>&#x2013;<lpage>1196</lpage>. <pub-id pub-id-type="doi">10.1016/j.mri.2013.04.008</pub-id> <pub-id pub-id-type="pmid">23684964</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>J. S.</given-names></name> <name><surname>Cho</surname> <given-names>S. K.</given-names></name> <name><surname>Kim</surname> <given-names>H. J.</given-names></name> <name><surname>Kim</surname> <given-names>Y. J.</given-names></name> <name><surname>Park</surname> <given-names>K. C.</given-names></name> <name><surname>Lockhart</surname> <given-names>S. N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Prediction models of cognitive trajectories in patients with nonamnestic mild cognitive impairment.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>8</volume>:<issue>10468</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-28881-1</pub-id> <pub-id pub-id-type="pmid">29993022</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname> <given-names>Y.</given-names></name> <name><surname>Mendell</surname> <given-names>N. R.</given-names></name> <name><surname>Rubin</surname> <given-names>D. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Testing the number of components in a normal mixture.</article-title> <source><italic>Biometrika</italic></source> <volume>88</volume> <fpage>767</fpage>&#x2013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1093/biomet/88.3.767</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLachlan</surname> <given-names>G.</given-names></name> <name><surname>Peel</surname> <given-names>D.</given-names></name></person-group> (<year>2000</year>). <source><italic>Finite Mixture Models.</italic></source> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Wiley</publisher-name>.</citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNeish</surname> <given-names>D.</given-names></name> <name><surname>Pena</surname> <given-names>A.</given-names></name> <name><surname>Vander Wyst</surname> <given-names>K. B.</given-names></name> <name><surname>Ayers</surname> <given-names>S. L.</given-names></name> <name><surname>Olson</surname> <given-names>M. L.</given-names></name> <name><surname>Shaibi</surname> <given-names>G. Q.</given-names></name></person-group> (<year>2021</year>). <article-title>Facilitating growth mixture model convergence in preventive interventions.</article-title> <source><italic>Prev. Sci.</italic></source> <pub-id pub-id-type="doi">10.1007/s11121-021-01262-3</pub-id> <comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">34235633</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Min</surname> <given-names>J. W.</given-names></name></person-group> (<year>2018</year>). <article-title>A longitudinal study of cognitive trajectories and its factors for Koreans aged 60 and over: a latent growth mixture model.</article-title> <source><italic>Int. J. Geriatr. Psychiatry</italic></source> <volume>33</volume> <fpage>755</fpage>&#x2013;<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1002/gps.4855</pub-id> <pub-id pub-id-type="pmid">29363183</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mormino</surname> <given-names>E. C.</given-names></name> <name><surname>Papp</surname> <given-names>K. V.</given-names></name></person-group> (<year>2018</year>). <article-title>Amyloid accumulation and cognitive decline in clinically normal older individuals: implications for aging and early Alzheimer&#x2019;s disease.</article-title> <source><italic>J. Alzheimers Dis.</italic></source> <volume>64</volume> <fpage>S633</fpage>&#x2013;<lpage>S646</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-179928</pub-id> <pub-id pub-id-type="pmid">29782318</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muth&#x00E9;n</surname> <given-names>L. K.</given-names></name> <name><surname>Muth&#x00E9;n</surname> <given-names>B.</given-names></name></person-group> (<year>2019</year>). <source><italic>Mplus User&#x2019;s Guide (Version 8.3)</italic></source>, <edition>8th Edn</edition>. <publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>Muth&#x00E9;n &#x0026; Muth&#x00E9;n</publisher-name>.</citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguena Nguefack</surname> <given-names>H. L.</given-names></name> <name><surname>Pag&#x00E9;</surname> <given-names>M. G.</given-names></name> <name><surname>Katz</surname> <given-names>J.</given-names></name> <name><surname>Choini&#x00E8;re</surname> <given-names>M.</given-names></name> <name><surname>Vanasse</surname> <given-names>A.</given-names></name> <name><surname>Dorais</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches.</article-title> <source><italic>Clin. Epidemiol.</italic></source> <volume>12</volume> <fpage>1205</fpage>&#x2013;<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S265287</pub-id> <pub-id pub-id-type="pmid">33154677</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname> <given-names>C.</given-names></name></person-group> (<year>2018</year>). <source><italic>World Alzheimer Report 2018: The State of the Art of Dementia Research: New Frontiers, 2018.</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf">https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf</ext-link> <comment>(accessed November 1, 2022)</comment>.</citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rusinek</surname> <given-names>H.</given-names></name> <name><surname>De Santi</surname> <given-names>S.</given-names></name> <name><surname>Frid</surname> <given-names>D.</given-names></name> <name><surname>Tsui</surname> <given-names>W. H.</given-names></name> <name><surname>Tarshish</surname> <given-names>C. Y.</given-names></name> <name><surname>Convit</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.</article-title> <source><italic>Radiology</italic></source> <volume>229</volume> <fpage>691</fpage>&#x2013;<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1148/radiol.2293021299</pub-id> <pub-id pub-id-type="pmid">14657306</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname> <given-names>G.</given-names></name></person-group> (<year>1978</year>). <article-title>Estimating the dimension of a model.</article-title> <source><italic>J. Ann. Stat.</italic></source> <volume>6</volume> <fpage>461</fpage>&#x2013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-10470-6_18</pub-id> <pub-id pub-id-type="pmid">25485372</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Small</surname> <given-names>B. J.</given-names></name> <name><surname>B&#x00E4;ckman</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Longitudinal trajectories of cognitive change in preclinical Alzheimer&#x2019;s disease: a growth mixture modeling analysis.</article-title> <source><italic>Cortex</italic></source> <volume>43</volume> <fpage>826</fpage>&#x2013;<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1016/S0010-9452(08)70682-8</pub-id> <pub-id pub-id-type="pmid">17941341</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>S. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Fast robust automated brain extraction.</article-title> <source><italic>Hum. Brain Mapp.</italic></source> <volume>17</volume> <fpage>143</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.10062</pub-id> <pub-id pub-id-type="pmid">12391568</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsikitis</surname> <given-names>V. L.</given-names></name> <name><surname>Lu</surname> <given-names>K. C.</given-names></name> <name><surname>Kim</surname> <given-names>J. S.</given-names></name> <name><surname>Billingsley</surname> <given-names>K. G.</given-names></name> <name><surname>Thomas</surname> <given-names>C. R.</given-names> <suffix>Jr.</suffix></name> <name><surname>Herzig</surname> <given-names>D. O.</given-names></name></person-group> (<year>2016</year>). <article-title>Nomogram for predicting overall survival and salvage abdominoperineal resection for patients with anal cancer.</article-title> <source><italic>Dis. Colon. Rectum.</italic></source> <volume>59</volume> <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/DCR.0000000000000507</pub-id> <pub-id pub-id-type="pmid">26651105</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Bodner</surname> <given-names>T. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Growth mixture modeling: identifying and predicting unobserved subpopulations with longitudinal data.</article-title> <source><italic>Organ. Res. Methods</italic></source> <volume>10</volume> <fpage>635</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1177/1094428106289397</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>R. S.</given-names></name> <name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Yu</surname> <given-names>L.</given-names></name> <name><surname>Bennett</surname> <given-names>D. A.</given-names></name> <name><surname>Boyle</surname> <given-names>P. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Normative cognitive decline in old age.</article-title> <source><italic>Ann. Neurol.</italic></source> <volume>87</volume> <fpage>816</fpage>&#x2013;<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1002/ana.25711</pub-id> <pub-id pub-id-type="pmid">32144793</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zijdenbos</surname> <given-names>A. P.</given-names></name> <name><surname>Forghani</surname> <given-names>R.</given-names></name> <name><surname>Evans</surname> <given-names>A. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Automatic &#x201C;pipeline&#x201D; analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.</article-title> <source><italic>IEEE Trans. Med. Imaging</italic></source> <volume>21</volume> <fpage>1280</fpage>&#x2013;<lpage>1291</lpage>. <pub-id pub-id-type="doi">10.1109/tmi.2002.806283</pub-id> <pub-id pub-id-type="pmid">12585710</pub-id></citation></ref>
</ref-list>
</back>
</article>
